IFM Investors Pty Ltd Trims Holdings in The Clorox Company (NYSE:CLX)

IFM Investors Pty Ltd lowered its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 1.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 26,185 shares of the company’s stock after selling 256 shares during the period. IFM Investors Pty Ltd’s holdings in Clorox were worth $4,266,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in CLX. Innealta Capital LLC acquired a new position in shares of Clorox during the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC grew its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the period. First Foundation Advisors acquired a new stake in shares of Clorox during the 1st quarter worth approximately $31,000. Family Firm Inc. purchased a new stake in shares of Clorox during the 2nd quarter valued at approximately $31,000. Finally, Quarry LP lifted its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. DA Davidson reissued a “neutral” rating and set a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Barclays lifted their price target on shares of Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a research report on Friday, October 11th. Finally, Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $150.14.

Get Our Latest Report on Clorox

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.51% of the company’s stock.

Clorox Trading Down 1.4 %

CLX opened at $156.69 on Friday. The business has a fifty day moving average price of $160.74 and a 200 day moving average price of $145.61. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The stock has a market capitalization of $19.46 billion, a price-to-earnings ratio of 81.19, a PEG ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. Sell-side analysts expect that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.11%. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.